<DOC>
	<DOC>NCT01723631</DOC>
	<brief_summary>The objective of this project is to characterize the response TRAP positive patients with Multiple Sclerosis (MS) and to evaluate the sensitivity and specificity of the method in order to develop a second time as a diagnostic tool in this disease. We plan to analyze the response TRAP over a hundred patients with various clinical stages SEP (relapsing, progressive forms) and compared to healthy controls,</brief_summary>
	<brief_title>Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>These criteria depend on the subgroup belongs to the patient. Signed consent Membership of a social security system Whatever the patient group or control: Processing immunosuppressive. Processing by a monoclonal antibody. Previous treatment with an immunosuppressant for a significant period of time (more than 6 months of oral treatment, more than 6 cycles of cyclophosphamide over 3 cures mitoxantrone). Carcinomatous pathology known evolving. People under guardianship. Pregnant women. Patients not motivated to study. Known patients with anemia (hemoglobin &lt;10g/100ml)</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>TRAP</keyword>
	<keyword>TRAP-My√©line</keyword>
</DOC>